Intrabodies: Production and promise

Drug Discovery Today

Volumn 9, Issue 22, 2004, Pages 960-966

  Stocks, Martin R ^a  

^a Iclectus Limited   (United Kingdom)

Author keywords

antibody; Drug Discovery; gene therapy; Intrabody; intracellular; protein; therapeutic

Indexed keywords

ANTIBODY;

ANTIBODY ISOLATION; ANTIBODY LIBRARY; ANTIBODY STRUCTURE; ANTIGEN BINDING; CELL FUNCTION; CELLULAR DISTRIBUTION; CYTOPLASM; DNA BINDING; DRUG INDUSTRY; ENDOPLASMIC RETICULUM; GENE TARGETING; NONHUMAN; PROTEIN TARGETING; REVIEW; TARGET CELL;

ANIMALS; ANTIBODIES; ANTIBODY FORMATION; BIOTECHNOLOGY; HUMANS; INTRACELLULAR SPACE; PHARMACEUTICAL PREPARATIONS;

EID: 7944230671     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6446(04)03269-6     Document Type: Review

References (60)

1. Kohler G., Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature. 256:1975;495-497
2. Griffiths A.D., et al. Isolation of high affinity human antibodies directly from large synthetic repertoires. EMBO J. 13:1994;3245-3260
3. Hanes J., Pluckthun A. In vitro selection and evolution of functional proteins by using ribosome display. Proc. Natl. Acad. Sci. U. S. A. 94:1997;4937-4942
4. Feldhaus M.J., et al. Flow-cytometric isolation of human antibodies from a nonimmune Saccharomyces cerevisiae surface display library. Nat. Biotechnol. 21:2003;163-170
5. Daugherty P.S., et al. Development of an optimized expression system for the screening of antibody libraries displayed on the Escherichia coli surface. Protein Eng. 12:1999;613-621
6. Chen G., et al. Isolation of high-affinity ligand-binding proteins by periplasmic expression with cytometric screening (PECS). Nat. Biotechnol. 19:2001;537-542
7. Biocca S., et al. Redox state of single chain Fv fragments targeted to endoplasmic reticulum, cytosol and mitochondria. Biotechnology. 13:1995;1110-1115
8. Marasco W.A., et al. Intracellular antibodies against HIV-1 envelope protein for AIDS gene therapy. Hum. Gene Ther. 9:1998;1627-1642
9. Steinberger P., et al. Functional deletion of the CCR5 receptor by intracellular immunization produces cells that are refractory to CCR5-dependent HIV-1 infection and cell fusion. Proc. Natl. Acad. Sci. U. S. A. 97:2000;805-810
10. Deshane J., et al. Targeted tumor killing via an intracellular antibody against erbB-2. J. Clin. Invest. 96:1995;2980-2989
11. Richardson J.H., et al. Phenotypic knockout of the high-affinity human interleukin 2 receptor by intracellular single-chain antibodies against the a subunit of the receptor. Proc. Natl. Acad. Sci. U. S. A. 92:1995;3137-3141
12. Mhashilkar A.M., et al. Intrabody-mediated phenotypic knockout of major histocompatibility complex class I expression in human and monkey cell lines and in primary human keratinocytes. Gene Ther. 9:2002;307-319
13. Antman K.H., Livingston D.M. Intracellular neutralization of SV40 tumor antigens following microinjection of specific antibody. Cell. 19:1980;627-635
14. Carlson J.R. A new means of inducibly inactivating a cellular protein. Mol. Cell. Biol. 8:1988;2638-2646
15. Biocca S., et al. Expression and targeting of intracellular antibodies in mammalian cells. EMBO J. 9:1990;101-108
16. Lobato M.N., Rabbitts T.H. Intracellular antibodies and challenges facing their use as therapeutic agents. Trends Mol. Med. 9:2003;390-396
17. Rondon I.J., Marasco W.A. Intracellular antibodies (intrabodies) for gene therapy of infectious diseases. Annu. Rev. Microbiol. 51:1997;257-283
18. Wheeler Y.Y., et al. Intrabody and Intrakine Strategies for Molecular Therapy. Mol. Ther. 8:2003;355-366
19. Biocca S., Cattaneo A. Intracellular immunization: antibody targeting to subcellular compartments. Trends Cell Biol. 5:1995;248-252
20. Tanaka T., Rabbitts T.H. Intrabodies based on intracellular capture frameworks that bind the RAS protein with high affinity and impair oncogenic transformation. EMBO J. 22:2003;1025-1035
21. Tanaka T., et al. Single Domain Intracellular Antibodies: A Minimal Fragment For Direct in vivo Selection of Antigen-specific Intrabodies. J. Mol. Biol. 331:2003;1109-1120
22. Colby D.W., et al. Development of a human light chain variable domain (VL) intracellular antibody specific for the amino terminus of huntingtin via yeast surface display. J. Mol. Biol. 342:2004;901-912
23. Jendrayko N., et al. Intradiabodies, bispecific, tetravalent antibodies for the simultaneous knockout of two cell surface receptors. J. Biol. Chem. 278:2003;47812-47819
24. Alvarez R.D., et al. A cancer gene therapy approach utilizing an anti-erbB-2 single-chain antibody-encoding adenovirus (AD21): a phase I trial. Clin. Cancer Res. 6:2000;3081-3087
25. Worn A., et al. Correlation between in Vitro Stability and in vivo Performance of Anti-GCN4 Intrabodies as Cytoplasmic Inhibitors. J. Biol. Chem. 275:2000;2795-2803
26. Wirtz P., Steipe B. Intrabody construction and expression III: Engineering hyperstable VH domains. Protein Sci. 8:1999;2245-2250
27. Auf der Maur A.A., et al. Direct in vivo screening of intrabody libraries constructed on a highly stable single-chain framework. J. Biol. Chem. 277:2002;45075-45085
28. Visintin M., et al. Selection of antibodies for intracellular function using a two-hybrid in-vivo system. Proc. Natl. Acad. Sci. U. S. A. 96:1999;11723-11728
29. Tse E., et al. Intracellular Antibody Capture Technology: Application to selection of intracellular antibodies recognising the BCR-ABL oncogenic protein. J. Mol. Biol. 317:2002;85-94
30. Visintin M., et al. The Intracellular Antibody Capture Technology (IACT): Towards a consensus sequence for intracellular antibodies. J. Mol. Biol. 317:2002;73-83
31. Auf der Maur A.A., et al. Antigen-independent selection of stable intracellular single-chain antibodies. FEBS Letters. 508:2001;407-412
32. Gennari F., et al. Direct Phage to Intrabody Screening (DPIS): Demonstration by isolation of cytosolic intrabodies against the TES1 site of Epstein Barr Virus latent membrane protein 1 (LMP1) that block NF-kB transactivation. J. Mol. Biol. 335:2004;193-207
33. Fields S., Song O. A novel genetic system to detect proteinprotein interactions. Nature. 340:1989;245-246
34. Tanaka T., et al. De novo production of diverse intracellular antibody libraries. Nucleic Acids Res. 31:2003;e32
35. Kolonin M.G., Finley R.L. Jr. Interaction mating methods in two-hybrid systems. Methods Enzymol. 328:2000;26-46
36. Lundstrom K. Latest development in viral vectors for gene therapy. Trends Biotechnol. 21:2003;117-122
37. Davis M.E. Non-viral gene delivery systems. Curr. Opin. Biotechnol. 13:2002;128-131
38. Ars A., Villaverde A. Modular protein engineering for non-viral gene therapy. Trends Biotechnol. 22:2004;371-377
39. Beyer F., et al. Decline of surface MHC I by adenoviral gene transfer of anti-MHC I intrabodies in human endothelial cells-new perspectives for the generation of universal donor cells for tissue transplantation. J. Gene Med. 6:2004;616-623
40. Allen T.M. Ligand-targeted therapeutics in anticancer therapy. Nat. Rev. Cancer. 2:2002;750-763
41. Dalkara D., et al. Intracytoplasmic delivery of anionic proteins. Mol. Ther. 9:2004;964-969
42. Elliott G., O'Hare P. Intercellular trafficking and protein delivery by a herpes virus structural protein. Cell. 88:1997;223-233
43. Joliot A., et al. Antennapedia homeobox peptide regulates neural morphogenesis. Proc. Natl. Acad. Sci. U. S. A. 88:1991;1864-1868
44. Avrameas A., et al. Polyreactive anti-DNA monoclonal antibodies and a derived peptide as vectors for the intracytoplasmic and intranuclear translocation of macromolecules. Proc. Natl. Acad. Sci. U. S. A. 95:1998;5601-5606
45. Frankel A., Pabo C. Cellular uptake of the Tat protein from human immunodeficiency virus. Cell. 55:1988;1189-1193
46. Lundberg M., et al. Cell Surface Adherence and Endocytosis of Protein Transduction Domains. Mol. Ther. 8:2003;143-150
47. Jo D., et al. Epigenetic regulation of gene structure and function with a cell-permeable Cre recombinase. Nat. Biotechnol. 19:2001;929-933
48. Peitz M., et al. Ability of the hydrophobic FGF and basic TAT peptides to promote cellular uptake of recombinant Cre recombinase: a tool for efficient genetic engineering of Mamm. Proc. Natl Acad. Sci. U. S. A. 99:2002;4489-4494
49. Joliot A., Prochiantz A. Transduction peptides: from technology to physiology. Nat. Cell Biol. 6:2004;189-196
50. Dykxhoorn D.M., et al. Killing the messenger: Short RNAs that silence gene expression. Nat. Rev. Mol. Cell Biol. 4:2003;457-467
51. Jackson A.L., et al. Expression profiling reveals off-target gene regulation by RNAi. Nat. Biotechnol. 21:2003;635-637
52. Bridge A.J., et al. Induction of an interferon response by RNAi vectors in mammalian cells. Nat. Genet. 34:2003;263-264
53. Murphy R.C., Messer A. A single-chain Fv intrabody provides functional protection against the effects of mutant protein in an organotypic slice culture model of Huntington's disease. Brain Res. Mol. Brain Res. 121:2004;141-145
54. Secco P., et al. Characterization of a single-chain intrabody directed against human receptor tyrosine kinase Ron. J. Immmunol. Methods. 285:2004;99-109
55. Rousselet N., et al. Inhibition of tumorigenicity and metastasis of human melanoma cells by anti-cathepsin L single chain variable fragment. Cancer Res. 64:2004;146-151
56. Boonrod K., et al. Single-chain anitbodies against a plant viral RNA-dependent polymerase confer virus resistance. Nat. Biotechnol. 22:2004;856-862
57. Zemel R., et al. Inhibition of hepatitis C virus NS3-mediated cell transformation by recombinant intracellular antibodies. J. Hepatol. 40:2004;1000-1007
58. Dekker S., et al. Intracellularly expressed single-domain antibody against p15 matrix protein prevents the production of porcine retroviruses. J. Virol. 77:2003;12132-12139
59. Wheeler Y.Y., et al. Intrabody-based strategies for inhibition of vascular endothelial growth factor receptor-2: effects on apoptosis, cell growth, and angiogenesis. FASEB J. 17:2003;1733-1735
60. Hyland S., et al. Generation and functional characterization of intracellular antibodies interacting with the kinase domain of human EGF receptor. Oncogene. 22:2003;1557-1567